A recent study set out to identify the types of containers from which young children accessed solid dose medications (SDMs) in the course of unsupervised medication exposures. Five US poisons centers in the USA enrolled individuals calling about unsupervised solid dose medication exposures by children. 62% of eligible callers participated. Among 4496 participants, 71.6% of SDM exposures involved children aged up to 2 years; 33.8% involved only prescription medications, 32.8% involved only over-the counter (OTC) products that require child-resistant packaging, and 29.9% involved and OTC product that does not require child-resistant packaging. CRITICALLY: 51.5% of cases involved prescription medications that had previously been removed from original packaging. The drugs involved were not innocuous either – medications for ADHD (49.3%) and opioids (42.6%) were often not in any container when accessed; anticonvulsants (41.1%), hypoglycemic agents (33.8%), and cardiovascular/antithrombotic agents (30.8%) were often transferred to alternate containers. GRANDPARENTS’ medications were involved in 30.7% of prescription medication exposures, but only 7.8% of OTC product exposures (aOR, 3.99; 95% CI, 3.26-4.87). It seems that older people with grandchildren or other young children who visit need to have it stressed to them that childproof packaging has a purpose and that medications should not be removed from this packaging until just before use. See the paper’s details in the Journal of Pediatrics, here.